Six-month open label extension to an efficacy and safety study of Ritalin LA in the treatment of adult patients with childhood-onset ADHD

Update Il y a 4 ans
Reference: EUCTR2011-000210-19

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

•To evaluate the long-term safety of Ritalin LA administered once daily for six months during open-label treatment in adults with ADHD.


Inclusion criteria

  • Adult patients with childhood-onset Attention Deficit Hyperactivity Disorder